These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15838876

  • 1. Interleukin-6 regulation of prostate cancer cell growth.
    Culig Z, Steiner H, Bartsch G, Hobisch A.
    J Cell Biochem; 2005 Jun 01; 95(3):497-505. PubMed ID: 15838876
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S, Cavarretta IT, Fuchs D, Fiechtl M, Steiner H, Friedbichler K, Bartsch G, Hobisch A, Culig Z.
    Prostate; 2005 Jul 01; 64(2):209-16. PubMed ID: 15712220
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
    Malinowska K, Neuwirt H, Cavarretta IT, Bektic J, Steiner H, Dietrich H, Moser PL, Fuchs D, Hobisch A, Culig Z.
    Endocr Relat Cancer; 2009 Mar 15; 16(1):155-69. PubMed ID: 19011039
    [Abstract] [Full Text] [Related]

  • 5. Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.
    Steiner H, Cavarretta IT, Moser PL, Berger AP, Bektic J, Dietrich H, Zaki MH, Nakada M, Hobisch A, Nemeth JA, Culig Z.
    Prostate; 2006 Dec 01; 66(16):1744-52. PubMed ID: 16998813
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 01; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 7. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.
    Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C.
    Prostate; 2004 Jun 15; 60(1):61-7. PubMed ID: 15129430
    [Abstract] [Full Text] [Related]

  • 8. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
    Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, Comuzzi B, Bartsch G, Hobisch A, Culig Z.
    Am J Pathol; 2003 Feb 15; 162(2):655-63. PubMed ID: 12547723
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A.
    J Mol Endocrinol; 2009 May 15; 42(5):429-35. PubMed ID: 19223455
    [Abstract] [Full Text] [Related]

  • 10. An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.
    Steiner H, Berger AP, Godoy-Tundidor S, Bjartell A, Lilja H, Bartsch G, Hobisch A, Culig Z.
    Eur J Cancer; 2004 May 15; 40(7):1066-72. PubMed ID: 15093584
    [Abstract] [Full Text] [Related]

  • 11. Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.
    Yan TZ, Jin FS, Xie LP, Li LC.
    Urol Int; 2008 May 15; 81(2):228-33. PubMed ID: 18758226
    [Abstract] [Full Text] [Related]

  • 12. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
    Kooijman R, Himpe E, Potikanond S, Coppens A.
    Growth Horm IGF Res; 2007 Oct 15; 17(5):383-91. PubMed ID: 17513150
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.
    Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ.
    Carcinogenesis; 2008 Jun 15; 29(6):1148-56. PubMed ID: 18487223
    [Abstract] [Full Text] [Related]

  • 16. [Interleukin-6 implication in prostate cancer].
    Cabrespine A, Bay JO, Verrelle P, Morel L.
    Bull Cancer; 2007 Jul 15; 94(7 Suppl):F29-34. PubMed ID: 17845991
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
    Culig Z, Bartsch G, Hobisch A.
    Mol Cell Endocrinol; 2002 Nov 29; 197(1-2):231-8. PubMed ID: 12431817
    [Abstract] [Full Text] [Related]

  • 20. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
    Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S.
    J Cell Biochem; 2006 Aug 15; 98(6):1408-23. PubMed ID: 16619263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.